Yes, Forteo (teriparatide) is very likely causing the elevated ionized calcium in your patient.
Stop the calcium supplementation entirely and recheck the ionized calcium level. If hypercalcemia persists after discontinuing calcium, you need to stop the Forteo as well 1.
Why This Is Happening
Teriparatide causes transient hypercalcemia as a known pharmacodynamic effect. The drug transiently increases serum calcium beginning approximately 2 hours after injection, peaking at 4-6 hours (median increase 0.4 mg/dL), and returning to baseline by 16-24 hours 1, 2. However, the FDA label explicitly states that FORTEO has not been studied in patients with pre-existing hypercalcemia and may exacerbate hypercalcemia 1.
The combination of Forteo plus calcium supplementation—even at half-dose—is creating an additive effect that's pushing your patient into sustained hypercalcemia. This is particularly problematic because:
- Hypercalcemia occurred in 11.1% of women on teriparatide in clinical trials (vs 1.5% on placebo) 3
- The guideline explicitly recommends serum calcium should be assessed prior to use and neither agent be used in patients with elevated serum calcium 4
- While most hypercalcemia is "mild, asymptomatic, and transient," prolonged or severe hypercalcemia can occur and may persist for days to weeks even after stopping the drug 5, 6, 7
Immediate Management Algorithm
- Stop all calcium supplementation immediately
- Recheck ionized calcium in 3-5 days (not within 16 hours of last Forteo dose to avoid catching the transient peak)
- If ionized calcium normalizes: Continue Forteo without calcium supplements; ensure adequate vitamin D only
- If ionized calcium remains elevated: Discontinue Forteo and manage hypercalcemia with hydration; calcium should normalize within days to weeks 6, 7
Critical Timing Consideration
If you're checking calcium levels, draw blood at least 16 hours after the last Forteo injection 3. Drawing during the 4-6 hour peak window will show falsely elevated levels that don't represent the patient's baseline calcium status.
Important Caveats
The FDA label warns to avoid Forteo in patients with underlying hypercalcemic disorders like primary hyperparathyroidism 1. Before restarting, ensure your patient doesn't have an undiagnosed parathyroid disorder (check PTH if not already done).
Case reports document that underweight patients may be at higher risk for prolonged hypercalcemia due to relative "overdosing" with the standard 20 mcg dose 5. Consider your patient's body habitus.
Do not restart calcium supplementation while on Forteo unless the patient develops symptomatic hypocalcemia, which is extremely unlikely given the drug's mechanism of action.
Patients can meet calcium needs through diet alone (dairy, leafy greens) while on teriparatide—supplementation is not mandatory despite osteoporosis guidelines typically recommending it 3.
The evidence strongly supports that the combination of Forteo plus calcium supplementation is causing your patient's hypercalcemia, and calcium should be discontinued first before considering stopping the more expensive and therapeutically important anabolic agent.